CRISPR Therapeutics AG Earning Date (CRSP)

USA |NASDAQ |USD

CRSP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 29, 2022 (est) Jun 30, 2022 - $-2.32 $9.44
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 29, 2022 (est) Jun 30, 2022 - $178.00K $900.70M

Crispr Therapeutics Ag's next estimated earnings date (based on same quarter last year's date) is Jul 29, 2022 for the fiscal quarter ending Jun 30, 2022.

CRSP Earnings Date & History Chart

CRSP Earnings & Revenue Forecast

CRSP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 21 $-2.27 $-2.64 $-1.81
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 23 $-8.99 $-10.41 $-7.19
Dec 2023 25 $-7.57 $-13.32 $-2.18

CRSP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 2 / 0 $-2.27 $-2.05 $-2.05
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 2 $-8.94 $-8.13 $-8.13
Dec 2023 1 / 1 $-7.56 $-6.75 $-6.75

CRSP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 15 $2.07M $0.00 $14.90M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 22 $9.91M $0.00 $90.94M
Dec 2023 25 $192.58M $0.00 $860.40M

CRSP Earnings Date & Revenue History

CRSP Earnings History

|
Show More
Show More

CRSP Revenue History

|
Show More
Show More

Crispr Therapeutics Ag Next Earnings Date & Report

CRSP May 2022 (FQ) Earnings Date & Report Preview

CRSP's next estimated earnings date (based on same quarter last year's report date) is Jul 29, 2022 for the fiscal quarter ending Jun 30, 2022.

Crispr Therapeutics Ag Previous Earnings Dates & Reports

CRSP Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Crispr Therapeutics Ag's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

CRSP's earnings per share (EPS) was $-2.32, missing the consensus analysts forecast of $-1.94 by -19.59%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 26.09%, and lower than the same period a year before (Mar 2021) by 53.64%.

Revenues were $178.00K, worse than the forecast of $2.76M by -93.55%, down by -98.62% from the previous quarter , and down by -66.98% from the same period last year.

The company reported a net income of $-179.22M.

Free cash flow for the quarter was $-150.59M , compared to $-95.22M last quarter and $-107.69M a year before.

CRSP ended the quarter with $238.98M in total debt, an increase of 6.20% compared to the previous quarter, and an increase of 288.77% compared to the same quarter a year before.

CRSP Previous Earnings Date & Report Recap: Dec 2021 (FY)

Crispr Therapeutics Ag's previous annual earnings date was Feb 15, 2022 for its fiscal year ended Dec 31, 2021.

CRSP's earnings per share (EPS) was $4.42, missing the consensus analysts forecast of $4.88 by -9.43% , and higher than the previous year's EPS (Dec 2020) by -183.55%.

Revenues were $914.96M, better than the forecast of $862.68M by 6.06%, and up by 127154.94% from previous year's revenue.

The company reported a net income of $377.66M.

Crispr Therapeutics Ag reported a free cash flow of $457.27M for its fiscal year, compared to $-256.72M a year ago.

The company ended the fiscal year with $225.03M in total debt, an increase of 266.33% compared to the previous year.